During the past decade, ICO Badalona conducted 170 clinical trials. In the 10-year time frame, 170 clinical trials started and 43 clinical trials were completed, i.e. on average, 25.3% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 31 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICO Badalona" #1 sponsor was "Hoffmann-La Roche" with 34 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 14 trials sponsored, "Fundación GECP" with 12 trials sponsored, "PETHEMA Foundation" with 9 trials sponsored and "SOLTI Breast Cancer Research Group" with 9 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICO Badalona" #1 collaborator was "AstraZeneca" with 7 trials as a collaborator, "Pfizer" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Apices Soluciones S.L." with 4 trials as a collaborator and "Breast International Group" with 4 trials as a collaborator. Other collaborators include 117 different institutions and companies that were collaborators in the rest 102 trials.

According to Clinical.Site data, the most researched conditions in "ICO Badalona" are "Breast Cancer" (20 trials), "Non Small Cell Lung Cancer" (9 trials), "Multiple Myeloma" (7 trials), "Non-Small Cell Lung Cancer" (7 trials) and "Melanoma" (5 trials). Many other conditions were trialed in "ICO Badalona" in a lesser frequency.

Most popular intervention types in "ICO Badalona" are "Drug" (183 trials), "Other" (14 trials), "Radiation" (11 trials), "Biological" (10 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Atezolizumab" (22 trials), "Carboplatin" (20 trials), "Paclitaxel" (15 trials) and "Cisplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "ICO Badalona" are 171 trials for "All" genders, 22 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 109 active trials in "ICO Badalona". 1 are not yet recruiting, 55 are recruiting, 51 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 69 completed trials in ICO Badalona, 1 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in ICO Badalona, 34 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".